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Abstract Mitochondrial calcium exchanges are involved in in- 
tracellular calcium homeostasis and in the contraction-relaxation 
process in myocytes. The calcium-induced permeability transition 
of the heart mitochondria inner membrane appears to be an 
important calcium efflux mechanism involved in some physiolog- 
ical and pathological situations. The negative inotropic effect of 
the anaesthetic propofol results in part from a decrease in intra- 
cellular calcium availability. Thus, this study evaluates the effects 
of propofol on calcium transport and permeability transition of 
heart mitochondria. The propofol-inhibition of the permeability 
transition of liver mitochondria was previously investigated 
[Eriksson, O. (1991) FEBS Lett. 279, 45-48] in such conditions 
that its uncoupling effect was not taken into account. We show 
here that propofol uncoupling results in a decrease in calcium 
uptake rate which could in part explain the decreased permeabil- 
ity transition rate. However, comparison of equlpotent uncou- 
pling concentrations of propofol and carbonylcyanide m-chloro- 
phenylhydrazone r veals that beyond this uncoupling effect, pro- 
pofol has a direct inhibitory action on the permeability transition 
pore, concomittant with a shift of its gating potential. 
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1. Introduction 
The short-acting intravenous anaesthetic propofol (2,6 diiso- 
propylphenol) is widely used. Unfortunately, induction of an- 
aesthesia with propofol can result in a significant decrease in 
arterial blood pressure, systemic vascular esistance and car- 
diac output. Some studies have demonstrated an intrinsic neg- 
ative inotropic effect of propofol [1,2]. Recently, it was sug- 
gested that this effect on myocardial contractility results from 
a decrease in intracellular Ca 2+ availability [3]. 
Mitochondria seem to play an important role in Ca 2+ home- 
ostasis in both non-excitable and excitable cells; moreover, 
mitochondria are Ca2+-excitable organelles which appear to be 
involved in the transduction of cell Ca 2+ signals [4]. The mech- 
anisms by which mitochondria transport Ca 2÷ are complex and 
numerous [5]. Ca 2÷ influx into energized mitochondria s poten- 
tial-dependent and occurs through the ruthenium red-sensitive 
Ca 2+ uniport. Two separate mechanisms are known to account 
for Ca > efflux from mitochondria: (i) a Ca2+/Na 2+ exchanger 
and (ii) a Ca2+-induced increase in membrane permeability. The 
biochemical mechanisms mediating this permeability ransition 
of the mitochondrial inner membrane have not been entirely 
elucidated. However, there is now considerable evidence that 
the mitochondrial membrane contains a latent pore: the perme- 
ability transition pore (PTP) or megachannel [6-13]. The PTP 
is a Ca2+-dependent and cyclosporin A (CsA)-sensitive. An 
increase in matrix Ca 2+ or in matrix pH, or a drop of membrane 
potential favour the opening of the pore [11 13]. The resulting 
permeability ransition is accompanied by a decrease in mem- 
brane potential, a loss of matrix ions including Ca 2÷, and mito- 
chondrial swelling. Very low concentrations (1 FtM) of CsA 
inhibit the permeability transition. 
Ca 2+ interactions in heart mitochondria are involved in some 
physiological or pathological processes [14-16]. In cardiac my- 
ocytes, Ca 2+ is a physiological regulator of mitochondrial me- 
tabolism and ATP synthesis [14]. Mitochondrial Ca 2÷ cycling 
might affect the sarcoplasmic reticulum Ca 2÷ content in the 
heart [17]. In myocytes, the PTP contributes to mitochondrial 
Ca 2÷ cycling and provides a pathway for mitochondrial Ca 2÷ 
extrusion [18]. 
Propofol and other substituted phenols are known to affect 
oxidative phosphorylation i  mitochondria [19,20]. Propofol 
acts as a mild protonophore-like uncoupler and reduces the 
mitochondrial membrane potential. In liver mitochondria, pro- 
pofol has been found to induce an apparent uptake of Ca 2+ and 
to stabilize the mitochondrial membrane by interaction with the 
PTP [21]. The aim of this study was to investigate the effects 
of propofol on the PTP in heart mitochondria. Mitochondrial 
swelling was used to monitor the Ca2+-induced permeability 
transition [22], and the mitochondrial Ca > uptake and release 
were investigated by measuring the external Ca 2÷ concentration 
with a Ca2+-sensitive electrode. The current study showed that 
propofol decreased both uptake and release by two different 
mechanisms. Comparison of the effects of propofol and the 
uncoupler carbonylcyanide m-chlorophenylhydrazone (CCCP) 
at an equipotent uncoupling concentration demonstrated that 
propofol inhibits the mitochondrial PTP and shifts its gating 
potential. 
*Corresponding author. Fax: (33) 56 99 03 80. 
Abbreviations: CCCP, carbonylcyanide m-chlorophenylhydrazone; 
CsA, cyclosporin A; HM, heart mitochondria; PTP, permeability tran- 
sition pore; RR, Ruthenium red. 
2. Material and methods 
2.1. Mitochondrial isolation 
Care of the animals conformed to the recommendations of the Insti- 
tutional Animal Care Committee and the French Ministry of Agricul- 
ture. Because all anaesthetic agents used could potentially alter mito- 
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chondrial function after isolation, adult male Wistar rats (weight 350 
400 g) were killed by cervical dislocation. The hearts were quickly 
removed and put into an ice-cold medium containing 70 mM sucrose, 
210 mM mannitol, 10 mM EDTA and 50 mM Tris-HCl (pH 7.4). 
Mitochondria were isolated by differential centrifugation aspreviously 
described [23]. Protein concentration f the mitochondrial suspension 
was determined by the Biuret method. All the experiments were carried 
out in a resin (Chelex-100)-treated buffer containing: 210 mM manni- 
tol, 70 mM sucrose, 5 mM HEPES-KOH (pH 7.4) and 0.2 mM 
KH2PO4. 
2.2. Mitochondrial swelling 
Changes in volume of the heart mitochondria were monitored at 540 
nm in a Perkin-Elmer spectrophotometer. Mitochondria (0.5 mg pro- 
tein/ml) were preincubated at30°C in the presence of rotenone (1 ktM) 
for 1 rain prior to the addition of Ca 2+ (200 nmol). Mitochondria were 
energized 1 min later by succinate (5 mM). The swelling rate was 
expressed as AA54olminlmg. 
2.3. Measurement of oxygen consumption a d external free calcium 
Measurements were made at 30°C in the 2 ml chamber of an ESON-6 
computerized analyzer (Mutual Data Inc., Moscow). Oxygen and free 
Ca 2÷ concentrations were measured in the medium with calibrated 
mini-electrodes [4]. 
2.4, Mitochondrial membrane potential 
Changes in membrane potential were measured by following fluores- 
cence of rhodamine 123 [24]. Mitochondria suspended in the same 
medium (0.25 mg/ml) were loaded with rhodamine 123 (0.1 pg/ml). 
Fluorescence was recorded in a fluorimeter (SFM125, Kontron) at the 
485-535 nm excitation-emission pair. Results were expressed in relative 
fluorescence intensity (Air, in %). AFo corresponded to the high mem- 
brane potential of energized mitochondria n the absence of adenosine 
diphosphate. 
2.5. Chemicals 
Cyclosporin A was a gift from Sandoz (Basle, Switzerland). All the 
other chemicals used were from Sigma. Propofol (2,6-diisopropylphe- 
nol) was dissolved in ethanol at 50 mM concentration. 
2.6. Data analysis 
Data were expressed as mean _+ standard eviation. The traces hown 
are representative of at least three experiments. Data were plotted 
and analyzed using KaleidaGraph (Synergy Software, Reading, 
PA). Concentration-reponse curves were fitted to the equation 
y = Min + (Max - Min)/(l + (Cs0/C)U), where C50 is the concen- 
tration producing half-maximal response and H is the Hill coefficient. 
Values for ICm were obtained from this curve fitting and are reported 
as + 95% confidence limits. Statistical nalysis was performed using the 
unpaired Student's t test. Differences at P < 0.05 were considered 
significant. 
3. Results 
3.1. Ca2+-induced permeability transition in heart mitochondria 
As previously reported [22], Ca 2÷ induced swelling of rat 
heart mitochondria (AA54o/min/mg = 0.42 _+ 0.07, n -- 5). Cy- 
closporin A (2 pM), a specific inhibitor of the PTP, inhibited 
swelling. Ruthenium red (1 pM) prevented Ca 2÷ accumulation 
by mitochondria nd consequently inhibited opening of the 
pore and swelling (Fig. 1). 
3.2. Propofol inhibition of the mitochondrial permeability 
transition 
Propofol, added before energization of mitochondria by suc- 
cinate, produced a dose-dependent inhibition of swelling (Fig. 
2). The concentration of propofol yielding 50% of the maximal 
inhibition (IC50) was 129 + 9/tM.  
Parallel measurements of Ca 2+ concentration i the medium 
showed two different effects of  propofol: a decrease in Ca 2+ 
S 
+ 
"': "::':':-':': - "-":~'." . . . . . . . . . . . . . . . . . . . .  b 
c5 
II 
c~ 
1 rain 
102 
Fig. 1. Heart mitochondrial swelling. Ca2+-induced permeability ransi- 
tion was monitored by the changes in volumes of mitochondria. Swel- 
ling was measured by the decrease in light scattering at 540 nm (A540). 
Heart mitochondria (HM), 0.5 mg/ml, were incubated at 30°C in a 
medium of 210 mM mannitol, 70 mM sucrose, 5 mM HEPES-KOH 
(pH 7.4), 0.2 mM KH2PO4 and rotenone 1pM. 200 nmol of Ca 2÷ and 
5 mM succinate (S) were added as indicated. Trace a: Ca2+-induced 
swelling. Traces b and c: inhibition of the swelling by 2 pM cyclosporin 
A (CsA) and 1 ,uM Ruthenium red (RR), respectively. 
uptake and an inhibition of Ca 2+ release which corresponded 
to the swelling inhibition (Fig. 3). The uncoupling effect of  
propofol on oxidative phosphorylation was responsible for a 
decrease in the Ca 2+ accumulation rate by a decline in the 
mitochondrial membrane potential. This effect could explain in 
part the apparent inhibition of the PTE 
3.3. Comparison propofol versus CCCP 
To prove a direct interaction between propofol and the PTP, 
we compared the effects of propofol and the classic uncoupler 
CCCE An equipotent uncoupling concentration was found for 
both molecules by studying their effects on mitochondrial respi- 
ration in the presence of succinate and on the membrane poten- 
tial (not shown). Propofol at 200 pM stimulated basal respira- 
tion (+ 57 + 15 nmol O/min/mg, n = 5) and decreased the mem- 
brane potential (-41 + 8% ofAF0, n -- 5). CCCP at 0.12/tM had 
no statistically different effects: +60 + 8 nmol O/min/mg 
(n = 5) and -45 + 9% of AFo (n = 5). 
At this concentration, CCCP inhibited Ca 2+ uptake and swel- 
ling like propofol (Fig. 3). Inhibition of swelling by CCCP was 
not due to an interaction with the PTP, but could be explained 
by the effect on Ca 2+ uptake. Indeed, CCCP was not able to 
block the PTP after Ca 2+ accumulation (Fig. 4). In contrast, 
when propofol (200/tM) was added at the end of Ca 2+ uptake 
just before the opening of the PTP, neither Ca 2÷ release nor 
swelling occurred (Fig. 4). These differences between CCCP 
and propofol could be explained by a direct inhibition of the 
PTP by propofol. 
4. Discussion 
Propofol is an intravenous anaesthetic agent with significant 
cardiovascular effects. In vitro studies have demonstrated the 
negative inotropic effect of propofol [1-3]. Cook et al. showed 
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Fig. 2. Inhibition of Ca2÷-induced swelling by propofol. (A) Swelling 
was followed as in Fig. 1. Propofol inhibited swelling in a concentra- 
tion-dependent manner. Trace a, Control; Traces b, c, d, Propofol 50 
pM, 100 HM and 200/IM, respectively. (B)Dose-dependent inhibition 
by propofol of the swelling rate, quantified as AA54olminlmg. Data are 
presented as mean + S.D. The data sets (n = 3 5 for each point) are 
fitted to the Hill equation with an IC50 of 129 + 9 /IM and a Hill 
coefficient of 4. 
in isolated ferret ventricular myocardium that propofol (30-300 
/~M concentration range) profoundly affected intracellular Ca 2+ 
availability by interfering with transsarcolemnal C  2+ influx [3]. 
The role played by mitochondria n intracellular Ca 2+ homeo- 
stasis has not been entirely elucidated. However, the discovery 
of the permeability ransition pore (PTP) in mitochondria has 
opened up a new area of research [5]. Mitochondria now appear 
to be CaZ+-excitable organelles involved in the transduction of
cell Ca 2+ signals [4]. Altschuld et al. have suggested that the 
opening and closing of the PTP in cardiomyocytes contribute 
to the process of Ca 2÷ release from mitochondria, nd that the 
PTP may be a normal pathway in functional heart cells [18]. 
The mitochondrial PTP is activated by Ca 2+ and inhibited by 
H +, Mg 2÷ and adenine nucleotides [8,13]. The specific inhibition 
by cyclosporin A characterizes the pore [7]. The open-closed 
transition of the PTP appears to be modulated by the mito- 
chondrial membrane potential (membrane depolarization fa- 
vours pore opening), the matrix pH and divalent cations 
[12,13]. This complexity of pore modulation means that an 
effector could have a direct or an indirect effect on the PTP. 
Propofol, like other substituted phenols, interacts with mito- 
chondrial oxidative phosphorylation. Propofol affects the cou- 
pling between the respiratory chain and ATP synthesis by act- 
ing as a mild protonophore [19,20]. This uncoupling effect ex- 
plains the decrease in transmembrane potential observed in the 
presence of propofol. Thus, the inhibition of the PTP by pro- 
pofol could be due to different effects: (i) a direct interaction 
with the PTP, or (ii) an indirect action due to the uncoupling 
effect of this molecule resulting in a decreased rate of Ca 2÷ 
accumulation. Unlike CCCP, propofol was able to inhibit both 
swelling and Ca 2+ release after addition at the end of Ca 2+ 
accumulation into the mitochondria (Fig. 4). These results indi- 
cate that propofol is a direct inhibitor of the PTP opening. 
Moreover, comparison of equipotent uncoupling concentra- 
tions of propofol and CCCP, in such conditions that mitochon- 
drial calcium load and matrix pH are identical (Fig. 4), shows 
that the voltage gating of the pore is shifted to lower values (i.e. 
for an equivalent loss of potential, CCCP increases the rate of 
the transition while propofol has an opposite ffect). 
The clinical relevance of this study is debatable, since the 
concentrations of propofol used here are higher than those 
normally encountered during anaesthesia. The concentrations 
of propofol at which significant PTP inhibition is observed (50 
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Fig. 3. Parallel measurements of mitochondrial swelling (A) and Ca 2÷ 
distribution (B). Swelling was monitored as in Fig. 1. Ca 2+ concentra- 
tion in the medium ([Ca2÷]0) was monitored simultaneously using a 
CaZ+-sensitive el ctrode. Trace a: after energization with succinate, Ca 2+ 
was accumulated into mitochondria and then released. Ca 2+ release was 
accompanied byswelling. Trace b: 200 pM propofol decreased the rate 
of Ca 2+ uptake and inhibited swelling. Trace c: 0.12 HM carbonylcya- 
nide m-chlorophenylhydrazone (CCCP) inhibited Ca z+ accumulation 
and swelling. 
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Fig. 4. Comparison of the activity of propofol and carbonylcyanide 
m-chlorophenylhydrazone (CCCP) on the mitochondrial permeability 
transition pore (PTP). Experimental conditions were the same as in Fig. 
3. To eliminate the effect of these molecules on Ca  2+ uptake and to 
concentrate only on the PTP, propofol and CCCP at an equipotent 
uncoupling concentration were added after energization by succinate 
and Ca 2÷ accumulation, just before the onset of the swelling. Trace a: 
control. Trace b: propofol (200 ktM) inhibited swelling (A) and Ca 2+ 
release (B) after Ca 2÷ accumulation i to the mitochondria. Trace c: 
CCCP (0.12/IM) had no inhibitory effect on the PTP opening. The 
inhibition of swelling by CCCP observed in Fig. 3 is thus explained by 
the sole decrease in Ca 2+ accumulation. 
pM) are at least tenfold the free plasma concentration detected 
after an intravenous bolus injection of propofol. However, the 
real cytosolic oncentrations of propofol in cardiomyocytes are 
unknown, and cumulative ffects of propofol after sustained 
intravenous administration have been reported [25]. The in- 
volvement of a propofol-PTP interaction in the cardiotoxicity 
of this anaesthetic remains to be evaluated. Thus, further stud- 
ies will be necessary to investigate the effects of propofol on 
mitochondria in situ using isolated cardiomyocytes. Altschuld 
et al. have shown that cyclosporin A inhibits the mitochondrial 
PTP in myocytes and leads to the accumulation of Ca 2+ by 
mitochondria [18]. These results could in part explain the effects 
ofcyclosporin A on cardiac muscle [26]. In the case ofpropofol, 
the mitochondrial functions could be disturbed both by an 
uncoupling effect with a decrease in energy production and by 
a change in mitochondrial Ca 2+ transport. 
In summary, this study reports a new effect of the anaesthetic 
propofol on mitochondrial Ca 2+ transport. The inhibition of 
the CaZ+-induced permeability ransition pore could play a role 
in the changes in intracellular Ca 2+ availability observed in the 
presence of propofol. 
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